Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 1
1988 1
1990 1
1991 1
1994 1
1995 1
1996 3
1997 3
1998 2
2000 3
2001 6
2003 5
2004 3
2005 3
2006 4
2007 6
2008 3
2009 3
2010 5
2011 7
2012 10
2013 8
2014 1
2015 9
2016 4
2017 3
2018 7
2019 5
2020 5
2021 10
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

117 results
Results by year
Filters applied: . Clear all
Page 1
Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data.
Sarkaria JN, Hu LS, Parney IF, Pafundi DH, Brinkmann DH, Laack NN, Giannini C, Burns TC, Kizilbash SH, Laramy JK, Swanson KR, Kaufmann TJ, Brown PD, Agar NYR, Galanis E, Buckner JC, Elmquist WF. Sarkaria JN, et al. Among authors: elmquist wf. Neuro Oncol. 2018 Jan 22;20(2):184-191. doi: 10.1093/neuonc/nox175. Neuro Oncol. 2018. PMID: 29016900 Free PMC article. Review.
Heterogeneous delivery across the blood-brain barrier limits the efficacy of an EGFR-targeting antibody drug conjugate in glioblastoma.
Marin BM, Porath KA, Jain S, Kim M, Conage-Pough JE, Oh JH, Miller CL, Talele S, Kitange GJ, Tian S, Burgenske DM, Mladek AC, Gupta SK, Decker PA, McMinn MH, Stopka SA, Regan MS, He L, Carlson BL, Bakken K, Burns TC, Parney IF, Giannini C, Agar NYR, Eckel-Passow JE, Cochran JR, Elmquist WF, Vaubel RA, White FM, Sarkaria JN. Marin BM, et al. Among authors: elmquist wf. Neuro Oncol. 2021 Dec 1;23(12):2042-2053. doi: 10.1093/neuonc/noab133. Neuro Oncol. 2021. PMID: 34050676 Free PMC article.
Efflux Limits Tumor Drug Delivery Despite Disrupted BBB.
Griffith JI, Sarkaria JN, Elmquist WF. Griffith JI, et al. Among authors: elmquist wf. Trends Pharmacol Sci. 2021 Jun;42(6):426-428. doi: 10.1016/j.tips.2021.03.001. Epub 2021 Mar 15. Trends Pharmacol Sci. 2021. PMID: 33736874
Preclinical Risk Evaluation of Normal Tissue Injury With Novel Radiosensitizers.
Dragojevic S, Ji J, Singh PK, Connors MA, Mutter RW, Lester SC, Talele SM, Zhang W, Carlson BL, Remmes NB, Park SS, Elmquist WF, Krishnan S, Tryggestad EJ, Sarkaria JN. Dragojevic S, et al. Among authors: elmquist wf. Int J Radiat Oncol Biol Phys. 2021 Dec 1;111(5):e54-e62. doi: 10.1016/j.ijrobp.2021.08.003. Epub 2021 Aug 14. Int J Radiat Oncol Biol Phys. 2021. PMID: 34400266 Review.
Localized Metabolomic Gradients in Patient-Derived Xenograft Models of Glioblastoma.
Randall EC, Lopez BGC, Peng S, Regan MS, Abdelmoula WM, Basu SS, Santagata S, Yoon H, Haigis MC, Agar JN, Tran NL, Elmquist WF, White FM, Sarkaria JN, Agar NYR. Randall EC, et al. Among authors: elmquist wf. Cancer Res. 2020 Mar 15;80(6):1258-1267. doi: 10.1158/0008-5472.CAN-19-0638. Epub 2019 Nov 25. Cancer Res. 2020. PMID: 31767628 Free PMC article.
Drug efflux transporters in the CNS.
Sun H, Dai H, Shaik N, Elmquist WF. Sun H, et al. Among authors: elmquist wf. Adv Drug Deliv Rev. 2003 Jan 21;55(1):83-105. doi: 10.1016/s0169-409x(02)00172-2. Adv Drug Deliv Rev. 2003. PMID: 12535575 Review.
117 results